Skip to main content
. 2025 Jul 28;21(11):4942–4960. doi: 10.7150/ijbs.112133

Figure 8.

Figure 8

Schematic diagram illustrating the mechanisms of IGF2BP3-mediated m6A modification of MALAT1 in promoting the malignant progression of HBV/HBx-related HCC, as well as potential strategies for epigenetic or genetic intervention.